Reference Show more | 1: Becherer JD, Boros EE, Carpenter TY, Cowan DJ, Deaton DN, Haffner CD, JeuneMR, Kaldor IW, Poole JC, Preugschat F, Rheault TR, Schulte CA, Shearer BG,Shearer TW, Shewchuk LM, Smalley TL Jr, Stewart EL, Stuart JD, Ulrich JC.Discovery of 4-Amino-8-quinoline Carboxamides as Novel, Submicromolar Inhibitorsof NAD-Hydrolyzing Enzyme CD38. J Med Chem. 2015 Sep 10;58(17):7021-56. doi:10.1021/acs.jmedchem.5b00992. Epub 2015 Aug 24. PubMed PMID: 26267483. 2: Tarragó MG, Chini CCS, Kanamori KS, Warner GM, Caride A, de Oliveira GC, RudM, Samani A, Hein KZ, Huang R, Jurk D, Cho DS, Boslett JJ, Miller JD, Zweier JL,Passos JF, Doles JD, Becherer DJ, Chini EN. A Potent and Specific CD38 InhibitorAmeliorates Age-Related Metabolic Dysfunction by Reversing Tissue NAD(+) Decline.Cell Metab. 2018 May 1;27(5):1081-1095.e10. doi: 10.1016/j.cmet.2018.03.016.PubMed PMID: 29719225; PubMed Central PMCID: PMC5935140. |